- Slice of Manufacturing
- Posts
- Kincell Bio Welcomes New Client for Cell Therapy Production
Kincell Bio Welcomes New Client for Cell Therapy Production
Slice of Manufacturing Team
September 19, 2024
Key Highlights:
Multi-year partnership for clinical-grade cell therapy production.
Focus on patient-specific batches for degenerative disease.
Gainesville, FL site adds to ongoing client projects.
Kincell Bio’s facility offers GMP-ready capabilities for critical manufacturing.
Source: Business Wire
Notable Quote:
“We’re delighted to welcome another client to our Gainesville facility. Our facility is GMP-ready, and our team thrives on providing critical CMC development and manufacturing expertise to support our clients’ clinical development plans to help patients.”
Our Take:
Kincell Bio’s announcement of a new multi-year contract showcases the company’s expanding presence in the cell therapy space. By focusing on patient-specific products, Kincell is demonstrating its ability to support complex therapeutic needs in degenerative diseases. This move also highlights the growing demand for specialized CDMO services in regenerative medicine, positioning Kincell as a key player in this field.